Free-Breathing 0.55T bSTAR: A New Frontier in Pulmonary MTR Imaging

Free-Breathing 0.55T bSTAR: A New Frontier in Pulmonary MTR Imaging

Read More
Full Text
Today

Introduction


Magnetic Resonance Imaging (MRI) of the lungs has historically faced challenges due to respiratory motion and low proton density. However, recent advancements in low-field technology have transformed this landscape. A groundbreaking study recently introduced 0.55T pulmonary MTR imaging using the bSTAR sequence. This method provides high-resolution, free-breathing scans that could revolutionize how clinicians diagnose and monitor chronic lung conditions.



The Shift to Low-Field MRI


While high-field MRI (1.5T or 3T) offers a higher signal-to-noise ratio, it often suffers from susceptibility artifacts in the lung parenchyma. In contrast, 0.55T systems significantly reduce these distortions. The lower magnetic field improves B0 field homogeneity and prolongs T2* relaxation times. Consequently, researchers can now capture clearer images of the delicate lung structure without the typical interference seen at higher strengths.



Technical Excellence of the bSTAR Sequence


The study compared several techniques, including gradient echo (GRE) and ultra-short TE (UTE) approaches. Notably, the self-gated 3D half-radial dual-echo balanced steady-state free precession (bSTAR) sequence demonstrated superior performance. Although all methods produced similar average Magnetization Transfer Ratio (MTR) values around 30 pu, bSTAR provided much higher resolution. Moreover, bSTAR completed the entire lung scan in roughly 8 minutes, making it highly suitable for clinical workflows. This sequence allows for free-breathing acquisition, which eliminates the need for difficult breath-hold maneuvers in compromised patients.



Clinical Implications for 0.55T Pulmonary MTR Imaging


The Magnetization Transfer Ratio serves as a sensitive indicator of macromolecular tissue composition. In this study, bSTAR MTR imaging successfully differentiated between healthy volunteers and patients with various pulmonary diseases. Because MTR values shift in response to tissue changes, this metric may serve as a noninvasive biomarker for fibrosis or inflammation. Furthermore, the high reproducibility of the bSTAR sequence ensures that clinicians can rely on these results for long-term patient monitoring.



Conclusion


The development of 0.55T pulmonary MTR imaging via bSTAR marks a significant step toward radiation-free lung diagnostics. By combining the physical advantages of low-field MRI with sophisticated pulse sequences, this technique offers a viable alternative to traditional CT scans. Ultimately, this approach could improve the characterization and differentiation of complex parenchymal abnormalities in everyday practice.



Frequently Asked Questions


How does 0.55T MRI benefit lung imaging compared to 1.5T?


Lower field strengths like 0.55T reduce magnetic susceptibility artifacts caused by the air-tissue interfaces in the lungs. This leads to more homogeneous images and better visualization of the lung parenchyma than what is typically possible at 1.5T or 3T.



What is the clinical value of the Magnetization Transfer Ratio (MTR)?


MTR provides information about the protein and macromolecular content of tissues. In pulmonary medicine, it can help detect pathological changes like fibrosis or cellular infiltration, potentially acting as a biomarker to distinguish between different lung diseases.



Is the bSTAR sequence suitable for patients who cannot hold their breath?


Yes, the bSTAR sequence uses a self-gated, free-breathing technique. This means patients can breathe naturally during the scan, which is a major advantage for those with severe respiratory distress or chronic obstructive pulmonary disease (COPD).



Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.



References


Braun A et al. Free-Breathing Magnetization Transfer Imaging of the Lung at 0.55 T Using bSTAR. Magn Reson Med. 2026 Mar 12. doi: 10.1002/mrm.70341. PMID: 41820220.


Bauman G et al. Submillimeter lung MRI at 0.55 T using balanced steady-state free precession with half-radial dual-echo readout (bSTAR). Magn Reson Med. 2023 Nov;90(5):1949-1957.


Campbell-Washburn AE et al. T2-weighted Lung Imaging Using a 0.55-T MRI System. Radiol Cardiothorac Imaging. 2021 Jun 17;3(3):e200611.

Login to continue

More from MedShots Daily

Free-Breathing 0.55T bSTAR: A New Frontier in Pulmonary MTR Imaging
Free-Breathing 0.55T bSTAR: A New Frontier in Pulmonary MTR Imaging

A study highlights 0.55T bSTAR as a high-resolution, free-breathing MRI method for lung imaging, potentially serving as a biomarker for pulmonary diseases....

Today

Read More
Full Text
The Dual Role of Amylin in Glucose Homeostasis and Beta-Cell Function
The Dual Role of Amylin in Glucose Homeostasis and Beta-Cell Function

A review of amylin's physiological benefits, its role in beta-cell cytotoxicity, and the therapeutic potential of amylin analogues in type 2 diabetes....

Today

Read More
Full Text
Schista Study Reveals Link Between Female Genital Schistosomiasis and High-Risk HPV
Schista Study Reveals Link Between Female Genital Schistosomiasis and High-Risk HPV

The Schista study in Zambia highlights a critical association between molecular female genital schistosomiasis (FGS) and oncogenic high-risk HPV genotypes....

Today

Read More
Full Text
Prevalence and Prognostic Impact of CKM Syndrome on TAVI Outcomes
Prevalence and Prognostic Impact of CKM Syndrome on TAVI Outcomes

A study of 5,834 patients reveals that CKM syndrome is present in 90% of TAVI candidates, significantly impacting procedural success and mortality rates....

Today

Read More
Full Text
China Approves First Commercial BCI to Restore Movement
China Approves First Commercial BCI to Restore Movement

China’s drug regulator has approved the world’s first commercial brain-computer interface (BCI) system to restore hand-grasping ability in paralyzed patient...

Today

Read More
Full Text
ACR Appropriateness Criteria for PNET Staging and Follow-Up
ACR Appropriateness Criteria for PNET Staging and Follow-Up

ACR provides evidence-based recommendations for PNET staging and follow-up, emphasizing CT, MRI, and DOTATATE PET/CT for optimal patient management....

Today

Read More
Full Text
Showing Page 1 of 1(5 items total)
Go to Page

"Wherever the art of Medicine is loved, there is also a love of Humanity."

— Hippocrates

made with❤️byOmnicuris
High-Resolution Lung MTR Imaging at 0.55T using bSTAR | Omnicuris